Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    12042765 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas
Conditions: Neoplasm;   Lymphoma
Intervention: Drug: LMP400
2 Recruiting A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas
Conditions: Neoplasms;   Lymphoma
Interventions: Drug: LMP 400;   Drug: LMP 776

Indicates status has not been verified in more than two years